{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:31:56Z","timestamp":1770831116770,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Empire Clinical Research Investigator Program","award":["ECRIP 2015-2017 program cycle"],"award-info":[{"award-number":["ECRIP 2015-2017 program cycle"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bbmt.2017.10.040","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T15:31:20Z","timestamp":1510155080000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"24","author":[{"given":"Jingmei","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Artz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Guarner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronit","family":"Reich-Slotky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Kline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-1494","authenticated-orcid":false,"given":"Melissa","family":"Cushing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsiporah B.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"van Besien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.10.040_bib0010","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jcyt.2016.07.003","article-title":"Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells","volume":"18","author":"Geyer","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40266-013-0076-x","article-title":"Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies","volume":"30","author":"William","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","article-title":"Diffuse large B-cell lymphoma: R-CHOP failure-what to do?","volume":"2016","author":"Coiffier","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0025","first-page":"237","article-title":"Do different conditioning regimens really make a difference?","author":"Castagna","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0035","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0040","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbmt.2011.10.016","article-title":"Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts","volume":"18","author":"Chen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0055","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0301-472X(03)00067-5","article-title":"Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor","volume":"31","author":"Fernandez","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0065","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.bbmt.2014.08.024","article-title":"Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders","volume":"20","author":"Kwon","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbmt.2012.08.019","article-title":"Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders","volume":"19","author":"Kwon","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.seminhematol.2016.07.004","article-title":"Haploidentical cord transplantation\u2014the best of both worlds","volume":"53","author":"van Besien","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbmt.2016.02.010","article-title":"Frequency and risk factors associated with cord graft failure (CGF) after Transplant with single unit umbilical cord cells supplemented by haploidentical cells (Haplo-Cord) with reduced-intensity conditioning","volume":"22","author":"Tsai","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcyt.2015.02.005","article-title":"Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells","volume":"17","author":"Lindemans","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0090","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.bbmt.2015.06.001","article-title":"Sufficient Immunosuppression with thymoglobulin is essential for a successful haplo-myeloid bridge in haploidentical-cord blood transplantation","volume":"21","author":"Lindemans","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0095","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbmt.2012.11.001","article-title":"Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications","volume":"19","author":"van Besien","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0100","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3109\/10428194.2012.739688","article-title":"Immune reconstitution after combined haplo-identical and umbilical cord blood transplantation","volume":"54","author":"Jain","year":"2012","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bmt.2013.177","article-title":"Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells","volume":"49","author":"Kwon","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0110","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3324\/haematol.2015.138594","article-title":"Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival","volume":"101","author":"van Besien","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0115","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/bmt.2017.36","article-title":"Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML","volume":"52","author":"Kwon","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2017.102","article-title":"Against the odds: haplo-cord grafts protect from GvHD and relapse","author":"Choe","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2017.10.040_bib0125","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/TP.0000000000001538","article-title":"The addition of low-dose total body irradiation to fludarabine and melphalan conditioning in haplocord transplantation for high-risk hematological malignancies","volume":"101","author":"Choe","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0130","article-title":"Cord blood transplantation supported by unrelated donor progenitor cells for patients without haplo identical relatives","author":"Van Besien","year":"2017","journal-title":"EBMT"},{"issue":"3","key":"10.1016\/j.bbmt.2017.10.040_bib0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcyt.2012.10.011","article-title":"Avoiding pitfalls in bone marrow engraftment analysis: a case study highlighting the weakness of using buccal cells for determining a patient's constitutional genotype after hematopoietic stem cell transplantation","volume":"15","author":"Rennert","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0150","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbmt.2008.01.008","article-title":"Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome","volume":"14","author":"Armand","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0160","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2010.32.8419","article-title":"Allogeneic transplantation for lymphoma","volume":"29","author":"Chakraverty","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3324\/haematol.2013.088997","article-title":"Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood","volume":"99","author":"Rodrigues","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/bmt.2014.259","article-title":"Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor","volume":"50","author":"Bachanova","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0180","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2017.10.040_bib0185","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/sj.bmt.1702372","article-title":"Unrelated cord blood transplantation vs matched unrelated donor bone marrow transplantation: the risks and benefits of each choice","volume":"25","author":"Mogul","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/10428194.2013.802780","article-title":"Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review","volume":"55","author":"Messer","year":"2014","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0195","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.5966\/sctm.2014-0151","article-title":"Concise review: umbilical cord blood transplantation: past, present, and future","volume":"3","author":"Munoz","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0200","article-title":"Cord blood chimerism and relapse after haplo-cord transplantation","author":"van Besien","year":"2016","journal-title":"Leuk Lymph"},{"issue":"8","key":"10.1016\/j.bbmt.2017.10.040_bib0205","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation","volume":"108","author":"Brunstein","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0210","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2014-09-599241","article-title":"Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation","volume":"126","author":"Pascal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/bmt.2016.265","article-title":"GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes","volume":"52","author":"Chen","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0220","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/10428194.2014.994180","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned","author":"Segovia","year":"2015","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0225","article-title":"Novel risk factors for Epstein-Barr Virus (EBV) reactivation and post-transplant lymphoproliferative disorder (PTLD) after allogeneic hematopoietic stem cell transplant","author":"Bachier","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2017.10.040_bib0230","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bmt.2016.19","article-title":"Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT","volume":"51","author":"Burns","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2013.11.010","article-title":"Allogeneic transplantation in T-cell lymphomas","volume":"51","author":"Schmitz","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/bmt.2017.26","article-title":"Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma","volume":"52","author":"Castagna","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0245","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1200\/JCO.2015.66.3476","article-title":"Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a center for international blood and marrow transplant research analysis","volume":"34","author":"Ghosh","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.10.040_bib0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbmt.2015.10.015","article-title":"Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning","volume":"22","author":"Brammer","year":"2016","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:09Z","timestamp":1761058869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117308091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1083879117308091"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.10.040","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}